Journal of Anaesthesiology Clinical Pharmacology

REVIEW ARTICLE
Year
: 2020  |  Volume : 36  |  Issue : 1  |  Page : 13--19

New and promising anti-bacterials: Can this promise be sustained?


Sai Saran1, Namrata S Rao2, Afzal Azim3 
1 Department of Critical Care Medicine, Super Speciality Cancer Institute and Hospital, CG City, India
2 Department of Nephrology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Uttar Pradesh, India
3 Department of Critical Care Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, Lucknow, Uttar Pradesh, India

Correspondence Address:
Prof. Afzal Azim
Department of Critical Care Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, Lucknow - 226 014, Uttar Pradesh
India

The World Health Organization (WHO) announced antimicrobial resistance (AMR) as a major threat to public health which requires that new antimicrobials need to be developed faster than ever before. The rapid development of resistance has rendered many promising antibacterials useless in treating critically ill patients. This article discusses new antibacterials, which got Food and Drug Administration (FDA) approval in the last few years, along with their key pharmacokinetic and pharmacodynamic (PK/PD) advantages, added antimicrobial spectrum, indications, strengths and weaknesses of these drugs from an intensivist point of view. A brief mention has been made on antimicrobial peptides (AMPs), bacteriophages and nanoparticles, which are likely to dominate the future of antibacterials. Finally, it must be understood that the battle against AMR can only be won by a combination of innovative therapies, good infection control practices, strong antibiotic stewardship in the hands of informed healthcare workers.


How to cite this article:
Saran S, Rao NS, Azim A. New and promising anti-bacterials: Can this promise be sustained?.J Anaesthesiol Clin Pharmacol 2020;36:13-19


How to cite this URL:
Saran S, Rao NS, Azim A. New and promising anti-bacterials: Can this promise be sustained?. J Anaesthesiol Clin Pharmacol [serial online] 2020 [cited 2020 Dec 5 ];36:13-19
Available from: https://www.joacp.org/article.asp?issn=0970-9185;year=2020;volume=36;issue=1;spage=13;epage=19;aulast=Saran;type=0